skip to Main Content

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Amyotrophic Lateral Sclerosis


Brief Summary:

This study seeks to correlate microbiome sequencing data with information provided by
patients and their medical records regarding ALS


Inclusion Criteria:

1. Signed informed consent, demonstrating that the patient understands the procedures
required for the study and the purpose of the study

2. Male or female patients of any age (interest is given to children to compare with

3. Diagnosis of ALS

Exclusion Criteria:

1. Refusal to sign informed consent form

2. History of bariatric surgery, total colectomy with ileorectal anastomosis or

3. Postoperative stoma, ostomy, or ileoanal pouch

4. Participation in any experimental drug protocol within the past 12 weeks

5. Treatment with total parenteral nutrition

6. Any clinically significant evidence of disease that could interfere with the subject’s
ability to enter the trial

7. Inability to adequately communicate with the investigator or their respective designee
and/or comply with the requirements of the entire study


  • ProgenaBiome, Ventura, California, United States, 93003
Back To Top